A prospective substance-treatment cohort found no clear overall reduction on its composite index, which included benzodiazepines and several other substances.
What the source reports
The study analyzed 881 measurements from 708 patients; only 171 supplied repeated measurements. Inpatient detoxification was not associated with a change in the index over time. Injection behavior was associated with higher severity and with worsening when patients began injecting.
Limits of the evidence
The index combines substances and frequencies, so a stable total can conceal improvement in one substance and worsening in another. Use was self-reported, follow-up was limited, and detoxification was not randomly allocated. The result is not a benzodiazepine-specific treatment-failure estimate.
Implications for forensic review
An expert should inspect how a composite score was constructed before interpreting “no change.” For an individual treatment history, track benzodiazepines separately from opioids, alcohol, stimulants, and other drugs. The paper supports careful outcome definition rather than a blanket conclusion that detoxification has no value.
Source and related reading
Source reviewed: Changes in substance use during outpatient treatment for substance use disorders a prospective Norwe (PMC8442290). This article summarizes the supplied paper; forensic applications above are interpretive analysis.
Related reading: Dominant Midazolam Sedation Was Associated With ICU Delirium in a Matched Cohort; Palliative Sedation Interviews Distinguish Treatment Intent From Expected Sedative Effects.
Leave a Reply